Novartis expands Global Research Headquarters in Cambridge

(The Boston Globe, November 13, 2013)

Swiss pharma giant Novartis, which plans to cut about 500 research jobs around the world while adding about 175 jobs at the company’s global research headquarters in Cambridge. The jobs at the Novartis Institutes for BioMedical Research will include some new hires along with other researchers moving from Horsham, England, where Novartis is closing a respiratory diseases research site, and Emeryville, CA, where it is shutting down a cancer research program. Novartis has become one of the largest biopharmaceutical players in the Boston area in recent years, employing about 2,400 people in Cambridge, including 1,800 in research. Novartis spends about $9 billion a year on research and development, more than almost any other large pharmaceutical company.